Glioblastoma Multiforme: a miPEP and miRNA Approach.
LOJ Pharmacology and Clinical Research. 2022 March; 3(1):293.
A Hypothetical Molecular Mechanism Linking Loss of BRCA1 Function to Infertility.
Interventions in Gynaecology and Women’s Healthcare. 2022 February; 5(2):508. doi: 10.32474/IGWHC.2022.05.000209.
ETS-Related Gene Activation Preserves Adherens Junctions and Permeability in Microvascular Endothelial Cells.
Shock.
2022 Feb 1;57(2):309-315. doi: 10.1097/SHK.0000000000001899. PubMed PMID:
34907119.
Inhibition of Aortic Medial Calcification: miPEP-200b and miRNA-200b as Potential Mediators.
LOJ Pharmacology and Clinical Research. 2021 August; 2(5):258.
ERG and Human Fli-1 Transcriptional Factors Play a role in the Precision Treatment of Pulmonary Arterial Hypertension and Pulmonary Fibrosis.
Journal of Cancer epidemiology & Treatment. 2019 June; 3(1):1.
Prognostic Impact of Lymph Node Ratio in Obstructive Colorectal Cancer.
J Can Epi Treat. 2017 April; 1(4):8-12.
Decoding of Non-Coding DNA and Non-Coding RNA.
Journal of Pharmaceutical Sciences and Pharmacology. 2017 March; 3(1):23.
BRCA1 Mutation Leads to Deregulated Ubc9 Levels which Triggers Proliferation and Migration of Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells.
Int J Chronic Dis Ther.
2016;2(3):31-38. Epub 2016 Jun 23. PubMed PMID:
28164176; PubMed Central PMCID:
PMC5287352.
Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells.
Clin Cancer Res.
2016 May 15;22(10):2545-54. doi: 10.1158/1078-0432.CCR-15-1927. Epub 2015 Dec 28. PubMed PMID:
26712693; PubMed Central PMCID:
PMC4867243.
Hyperthermia using nanoparticles--Promises and pitfalls.
Int J Hyperthermia.
2016;32(1):76-88. doi: 10.3109/02656736.2015.1120889. Epub 2016 Jan 12. Review. PubMed PMID:
26757879; PubMed Central PMCID:
PMC4955578.
Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features.
Cancer Causes Control.
2016 Jan;27(1):81-91. doi: 10.1007/s10552-015-0685-2. Epub 2015 Nov 23. PubMed PMID:
26596855; PubMed Central PMCID:
PMC4703620.
Molecular Mechanism of β-Catenin Signaling Pathway Inactivation in ETV1-Positive Prostate Cancers.
J Pharm Sci Pharmacol.
2015 Sep;2(3):208-216. doi: 10.1166/jpsp.2015.1069. PubMed PMID:
28497076; PubMed Central PMCID:
PMC5423671.
Anal Squamous Cell Carcinoma in African Americans with and without HIV: A Comparative Study.
J Cancer Epidemiol Treat.
2015;1(1):6-10. doi: 10.24218/jcet.2015.04. Epub 2015 Jul 3. PubMed PMID:
27774311; PubMed Central PMCID:
PMC5074337.
Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites.
J Gynecol Res.
2015;1(1). doi: 10.15744/2454-3284.1.103. Epub 2015 Apr 24. PubMed PMID:
26665166; PubMed Central PMCID:
PMC4671517.
Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells.
J Pharm Sci Pharmacol.
2014 Sep 1;1(3):175-181. doi: 10.1166/jpsp.2014.1022. PubMed PMID:
25745638; PubMed Central PMCID:
PMC4347898.
Anti-Epileptic Drug Targets Ewing Sarcoma.
J Pharm Sci Pharmacol.
2014 Jun 1;1(2):87-100. doi: 10.1166/jpsp.2014.1013. PubMed PMID:
25664332; PubMed Central PMCID:
PMC4316750.
Epithelial ovarian cancer: An overview.
World J Transl Med.
2014 Apr 12;3(1):1-8. doi: 10.5528/wjtm.v3.i1.1. PubMed PMID:
25525571; PubMed Central PMCID:
PMC4267287.
Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers.
J Pharm Sci Pharmacol.
2014 Mar;1(1):82-85. doi: 10.1166/jpsp.2014.1008. PubMed PMID:
25679011; PubMed Central PMCID:
PMC4322943.
Community health workers support community-based participatory research ethics: lessons learned along the research-to-practice-to-community continuum.
J Health Care Poor Underserved.
2012 Nov;23(4 Suppl):77-87. doi: 10.1353/hpu.2012.0156. PubMed PMID:
23124502; PubMed Central PMCID:
PMC3586526.
Translation to practice of an intervention to promote colorectal cancer screening among African Americans.
Clin Transl Sci.
2012 Oct;5(5):412-5. doi: 10.1111/j.1752-8062.2012.00439.x. Epub 2012 Aug 7. PubMed PMID:
23067354; PubMed Central PMCID:
PMC3476058.
BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9.
Am J Cancer Res.
2012;2(5):540-8. Epub 2012 Aug 20. PubMed PMID:
22957306; PubMed Central PMCID:
PMC3433105.
A comparison of breast and cervical cancer legislation and screening in Georgia, North Carolina, and South Carolina.
J Health Care Poor Underserved.
2012 May;23(2 Suppl):98-108. doi: 10.1353/hpu.2012.0074. PubMed PMID:
22643558; PubMed Central PMCID:
PMC3751800.
Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins.
J Cell Physiol.
2011 Dec;226(12):3355-67. doi: 10.1002/jcp.22695. PubMed PMID:
21344391; PubMed Central PMCID:
PMC3329759.
Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.
Int J Oncol.
2011 Jul;39(1):111-9. doi: 10.3892/ijo.2011.1014. Epub 2011 Apr 21. PubMed PMID:
21519790; PubMed Central PMCID:
PMC3329756.
Increased Black-White disparities in mortality after the introduction of lifesaving innovations: a possible consequence of US federal laws.
Am J Public Health.
2010 Nov;100(11):2176-84. doi: 10.2105/AJPH.2009.170795. Epub 2010 Sep 23. PubMed PMID:
20864727; PubMed Central PMCID:
PMC2951928.
A trial of 3 interventions to promote colorectal cancer screening in African Americans.
Cancer.
2010 Feb 15;116(4):922-9. doi: 10.1002/cncr.24842. PubMed PMID:
20052732; PubMed Central PMCID:
PMC2819540.
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
Int J Cancer.
2009 Nov 15;125(10):2288-95. doi: 10.1002/ijc.24574. PubMed PMID:
19610059; PubMed Central PMCID:
PMC3600527.
CBP-mediated post-translational N-glycosylation of BRCA2.
Int J Oncol.
2009 Aug;35(2):387-91. PubMed PMID:
19578754.
Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.
J Cell Physiol.
2009 Jun;219(3):634-41. doi: 10.1002/jcp.21708. PubMed PMID:
19170108; PubMed Central PMCID:
PMC3693557.
A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
Int J Oncol.
2009 Apr;34(4):939-49. doi: 10.3892/ijo_00000220. PubMed PMID:
19287951; PubMed Central PMCID:
PMC7983531.
CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth.
Mol Cancer Ther.
2009 Jan;8(1):178-84. doi: 10.1158/1535-7163.MCT-08-0643. PubMed PMID:
19139127; PubMed Central PMCID:
PMC3600559.
The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability.
Oncogene.
2008 Jul 3;27(29):4107-14. doi: 10.1038/onc.2008.34. Epub 2008 Feb 25. PubMed PMID:
18297113; PubMed Central PMCID:
PMC7983366.
BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.
Oncogene.
2007 Sep 6;26(41):6031-7. doi: 10.1038/sj.onc.1210420. Epub 2007 Mar 26. PubMed PMID:
17384678.
Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1.
Oncogene.
2004 Sep 16;23(42):7087-94. doi: 10.1038/sj.onc.1207927. PubMed PMID:
15273724.
EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function.
Oncogene.
2001 Oct 11;20(46):6653-9. doi: 10.1038/sj.onc.1204684. PubMed PMID:
11709699.
c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
Oncogene.
2001 Mar 15;20(11):1357-67. doi: 10.1038/sj.onc.1204256. PubMed PMID:
11313879.
Structure and expression of variant BRCA2a lacking the transactivation domain.
Oncol Rep.
1999 Mar-Apr;6(2):437-40. PubMed PMID:
10023017.
Fli-1b is generated by usage of differential splicing and alternative promoter.
Oncogene.
1998 Sep 3;17(9):1149-57. doi: 10.1038/sj.onc.1202030. PubMed PMID:
9764825.
Induction of apoptosis by Elk-1 and deltaElk-1 proteins.
Oncogene.
1998 Jul 30;17(4):527-32. doi: 10.1038/sj.onc.1201931. PubMed PMID:
9696047.
Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells.
Proc Natl Acad Sci U S A.
1998 Jul 7;95(14):8239-44. doi: 10.1073/pnas.95.14.8239. PubMed PMID:
9653171; PubMed Central PMCID:
PMC20960.
Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b.
Oncol Rep.
1998 May-Jun;5(3):585-9. doi: 10.3892/or.5.3.585. PubMed PMID:
9538156.
BRCA1 splice variants BRCA1a and BRCA1b associate with CBP co-activator.
Oncol Rep.
1998 May-Jun;5(3):591-5. doi: 10.3892/or.5.3.591. PubMed PMID:
9538157.
The BRCA2 is a histone acetyltransferase.
Oncogene.
1998 Apr 30;16(17):2283-5. doi: 10.1038/sj.onc.1202003. PubMed PMID:
9619837.
BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Oncogene.
1997 Jul 10;15(2):143-57. doi: 10.1038/sj.onc.1201252. PubMed PMID:
9244350.
Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
Oncogene.
1997 Mar 20;14(11):1259-68. doi: 10.1038/sj.onc.1201099. PubMed PMID:
9178886.
Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts.
Oncogene.
1996 Feb 1;12(3):523-8. PubMed PMID:
8637708.
The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator.
Oncogene.
1996 Jan 4;12(1):159-67. PubMed PMID:
8552387.
Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
Oncogene.
1995 Sep 21;11(6):1049-54. PubMed PMID:
7566963.
TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
Oncogene.
1994 Dec;9(12):3717-29. PubMed PMID:
7970732.
The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.
Oncogene.
1994 Oct;9(10):3087-97. PubMed PMID:
8084618.
What would you like to do?